Lack of enantiospecificity of human 2'-deoxycytidine kinase: Relevance for the activation of β-L-deoxycytidine analogs as antineoplastic and antiviral agents

Molecular Pharmacology

Volumn 51, Issue 1, 1997, Pages 132-138

  Verri, Annalisa ^a   Focher, Federico ^a   Priori, Giuseppina ^a   Gosselin, Gilles ^b   Imbach, Jean Louis ^b   Capobianco, Massimo ^a   Garbesi, Anna ^a   Spadari, Silvio ^a,c  

^a CNR   (Italy)

^b CNRS   (France)

^c Istituto di Genetica Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; NUCLEOSIDE TRIPHOSPHATE; THYMIDINE KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CELL CULTURE; CYTOTOXICITY; DNA SYNTHESIS; ENANTIOMER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; STEREOSPECIFICITY;

EID: 0031028279     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.1.132     Document Type: Article

References (36)

1. Hassan, H. F., and G. H. Coombs. Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol. Rev. 54:47-84 (1988).
2. Wang, C. C. Parasite enzymes as potential targets for antiparasitic chemotherapy. J. Med. Chem. 27:1-9 (1984).
3. Kornberg, A., and T. A. Baker. DNA Replication. Freeman and Co., New York (1991).
4. Momparler, R. L., and G. A. Fischer. Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside. J. Biol. Chem. 243:4298-4304 (1968).
5. Yamada, M., J. Aucker, and A. Weissbach. Formation of deoxycytidine diphosphate-diglyceride by nuclei isolated from HeLa cells. Arch. Biochem. Biophys. 177:461-467 (1976).
6. Eriksson, S., B. Kierdaszuk, B. Munch-Petersen, B. Öberg, and N. G. Johansson. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem. Biophys. Res. Commun. 176:586-592 (1991).
7. Krenitsky, T. A., J. V. Tuttle, G. W. Koszalka, I. S. Chen, L. M. Beacham III, J. L. Rideout, and G. B. Elion. Deoxycytidine kinase from calf thymus. J. Biol. Chem. 251:4055-4061 (1976).
8. Harrison, P. T., R. Thompson, and A. J. Davison. Evolution of herpesvirus thymidine kinase from cellular deoxycytidine kinase. J. Gen. Virol. 72: 2583-2586 (1991).
9. Spadari, S., G. Maga, F. Focher, G. Ciarrocchi, R. Manservigi, F. Arcamone, M. Capobianco, A. Carcuro, F. Colonna, S. Iotti, and A. Garbesi. L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidme kinase and inhibits viral growth. J. Med. Chem. 35:4214-4220 (1992).
10. 2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine and thymidylate kinases share a common active site. Biochem. J. 302:279-282 (1994).
11. Spadari, S., G. Ciarrocchi, F. Focher, A. Verri, G. Maga, F. Arcamone, E. Iafrate, S. Manzini, A. Garbesi, and L. Tondelli. 5-Iodo-2′-deoxy-L-uridine and (E)-5-(2-bromovinyl)2′-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity and cytotoxicity studies. Mol. Pharmacol. 47:1231-1238 (1995).
12. Maga, G., A. Verri, W. Ponti, L. Bonizzi, G. Poli, A. Garbesi, D. Niccolai, S. Spadari, and F. Focher. Lack of stereospecificity of suid pseudorabies virus (PRV) thymidine kinase. Biochem. J. 294:381-385 (1993).
13. Shewach, D. S., D. C. Liotta, and R. F. Schinazi. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2′-deoxycytidine kinase. Biochem. Pharmacol. 45:1540-1543 (1993).
14. Dixon, M., and E. C. Webb. Enzymes. Longam Group Limited, London (1979).
15. Eriksson, S., E. Arner, T. Spasokoukotskaja, L. Wang, A. Karsson, O. Brosjö, P. Gunvén, G. Julusson, and J. Liliemark. Properties and levels of deoxynucleoside kinases in normal and tumor cells: implication for chemotherapy, in Advances in Enzyme Regulation (A. H. Cory and J. G. Cory, eds.). Pergamon Press, Oxford, 13-25 (1994).
16. Schinazi, R. F., A. McMillan, D. Cannon, R. Mathis, R. M. Lloyd, A. Peck, L. P. Sommadossi, M. St. Clair, J. Wilson, P. A. Furman, G. Painter, W. B. Choi, and D. C. Liotta. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2423-2431 (1992).
17. Schinazi, R. F., C. K. Chu, A. Peck, A. McMillan, R. Mathis, D. Cannon, L. S. Jeong, J. W. Beach, W. B. Choi, S. Yeola, and D. C. Liotta. Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes. Antimicrob. Agents Chemother. 36:672-676 (1992).
18. Chang, C.-N., V. Skalski, J. H. Zhou, and Y. Cheng. Biochemical pharmacology of (+) and (-)-2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents. J. Biol. Chem. 267:22414-22420 (1992).
19. Chang, C. N., S. L. Doong, J. H. Zhou, J. W. Beach, L. S. Jeong, C. K. Chu, C. H. Tsai, Y.-C. Cheng, D. Liotta, and R. Schinazi. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J. Biol. Chem. 267:13938-13942 (1992).
20. Lin, T. S., M. Z. Luo, M. C. Liu, S. B. Pai, G. E. Dutschman, and Y.-C. Cheng. Synthesis and biological evaluation of 2′,3′-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). J. Med. Chem. 37:798-803 (1994).
21. Gosselin, G., R. F. Schinazi, J.-P. Sommadossi, C. Mathè, M.-C. Bergogne, A.-M. Aubertin, A. Kirn, and J.-L. Imbach. Anti-human immunodeficiency virus activity of the β-L enantiomer of 2′,3′-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrob. Agents. Chemother. 38:1292-1297 (1994).
22. Faraj, A., L. A. Agrofoglio, J. K. Wakefield, S. McPherson, C. D. Morrow, G. Gosselin, C. Mathe, J.-L. Imbach, R. F. Schinazi, and J.-P. Sommadossi. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5′-triphosphate ß enantiomers of cytidine analogs. Antimicrob. Agents Chemother. 38:2300-2305 (1994).
23. Holy, A. Nucleic acid components and their analogs. CLIII. Preparation of 2′deoxy-L-ribonucleosides of the pyrimidine series. Collect. Czech. Chem. Commun. 37:4072-4087 (1972).
24. Gosselin, G., M.-C. Bergogne, and J.-L. Imbach. Synthesis and antiviral evaluation of β-L-xylo-furanosyl nucleosides of the five naturally occurring nucleic acid bases. J. Heterocyclic Chem. 30:1229-1233 (1993).
25. Genu-Dellac, C., G. Gosselin, F. Puech, J.-C. Henry, A.-M. Aubertin, G. Obert, A. Kirn, and J.-L. Imbach. Systematic synthesis and antiviral evaluation of α-L-arabinofuranosyl and 2′-deoxy-α-L-erythropentofuranosyl nucleosides of the five naturally occurring nucleic acid bases. Nucleosides Nucleotides 10:1345-1376 (1991).
26. Yamaguchi, T., and M. Saneyoshi. Synthetic nucleosides and nucleotides. XXI. On the synthesis and biological evaluations of 2′-deoxy-α-D-ribofuranosyl nucleosides and nucleotides. Chem. Pharm. Bull. 32:1441-1450 (1984).
27. Gosselin, G., C. Mathé, M.-C. Bergogne, A.-M. Aubertin, J.-P. Sommadossi, R. Schinazi, and J.-L. Imbach. 2′- And/or 3′-deoxy-β-pentofuranosyl nucleoside derivatives: stereospecificity synthesis and antiviral activities. Nucleosides Nucleotides 14:611-617 (1995).
28. Cacciamani, T., A. Vita, G. Cristalli, S. Vincenzetti, P. Natalini, R. S., A. Amici, and G. Magni. Purification of human cytidine deaminase: molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs. Arch. Biochem. Biophys. 298:285-292 (1991).
29. Fanucchi, M. P., K. A. Watanabe, J. J. Fox, and T.-C. Chou. Kinetics and substrate specificity of human and canine cytidine deaminase. Biochem. Pharmacol. 35:1199-1201 (1986).
30. Jurovcik, M., and A. Holy. Metabolism of pyrimidine L-nucleosides. Nucleic Acids Res. 3:2143-2154 (1976).
31. Hübscher, U., and S. Spadari. DNA replication and chemotherapy. Physiol. Rev. 74:259-304 (1994).
32. Focher, F., G. Maga, A. Bendiscioli, M. Capobianco, F. Colonna, A. Garbesi, and S. Spadari. Stereospecificity of human DNA polymerases α, β, γ, and ∈, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and E. coli DNA polymerase I in recognizing D- and L-thymidine 5′-triphosphate as substrate. Nucleic Acids Res. 23: 2840-2847 (1995).
33. Yamaguchi, T., N. Iwanami, K. Shudo, and M. Saneyoshi. Chiral discrimination of enantiomeric 2′-deoxythymidine 5′-triphosphate by HIV-reverse transcriptase and eukaryotic DNA polymerases. Biochem. Biophys. Res. Commun. 200:1023-1027 (1994).
34. Kukhanova, M., S.-H. Liu, D. Mozzerin, T.-S. Lin, C. K. Chu, and Y.-C. Cheng. L- And D-enantiomers of 2′,3′-dideoxycytidine 5′-triphosphate analogs as substrate for human DNA polymerases. J. Biol. Chem. 270: 23055-23059 (1995).
35. Semizarov, D. G., L. S. Victorova, N. B. Dyatkina, M. von Janta-Lipinski, and A. A. Krayevsky. Selectivity of DNA polymerases toward α and β nucleotide substrates of D and L series. FEBS Lett. 354:187-190 (1994).
36. Van Draanen, N. A., S. C. Tucker, F. L. Boyd, B. W. Trotter, and J. E. Reardon. β-L-Thymidine 5′-triphosphate analogs as DNA polymerase substrates. J. Biol. Chem. 267:25019-25024 (1992).